2023-05-03 08:41:11 ET
- Clinical-stage company and leader in cell therapeutics, Sernova ( OTCQB:SEOVF ) entered into a preclinical research collaboration with AstraZeneca ( AZN ) to evaluate the use of Sernova’s Cell Pouch System in combination with AstraZeneca’s novel therapeutic cells.
- AstraZeneca is exploring the use of Sernova’s Cell Pouch System as a potential platform for integration with its development of the next wave of innovative cell therapies for various indications.
For further details see:
Sernova joins hands with AstraZeneca for potential therapeutic cell applications